Global Nucleic Acid Delivery Excipients Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Nucleic Acid Delivery Excipients Market Insights, Forecast to 2034
Nucleic acids, including plasmid DNA, oligonucleotides, small interfering RNA, messenger RNA and micro RNA provide significant promise in the treatment of challenging diseases. Unfortunately, their delivery as therapeutic agents has been a challenge. Nanoparticulate delivery systems, in which cationic lipids or polymers condense nucleic acids to form “lipoplex” or “polyplex” via the negative phosphate groups of nucleic acids show high productivity and loading efficiency. The intracellular delivery of these complexes is believed to occur via endocytosis followed by endosomal escape into the cytoplasm.
Global Nucleic Acid Delivery Excipients market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Nucleic Acid Delivery Excipients industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Nucleic Acid Delivery Excipients key manufacturers include Avanti Polar Lipids, Alfa Chemistry, Evonik Health Care, Phosphorex, Creative Biolabs, Celares, VectorBuilder, Seqens and BroadPharm, etc. Avanti Polar Lipids, Alfa Chemistry, Evonik Health Care are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Nucleic Acid Delivery Excipients were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Nucleic Acid Delivery Excipients market and estimated to attract more attentions from industry insiders and investors.
Nucleic Acid Delivery Excipients can be divided into Cationic Lipids, pH-sensitive Lipids, Phospholipids and PEG Lipids, etc. Cationic Lipids is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Nucleic Acid Delivery Excipients is widely used in various fields, such as Lipid Nanoparticles for mRNA/siRNA/DNA, Transfection Vectors for Gene Therapies, Immunotherapies (CAR-T-Cells) and Lipid Prodrugs, etc. Lipid Nanoparticles for mRNA/siRNA/DNA provides greatest supports to the Nucleic Acid Delivery Excipients industry development. In 2022, global % sales of Nucleic Acid Delivery Excipients went into Lipid Nanoparticles for mRNA/siRNA/DNA filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Nucleic Acid Delivery Excipients market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Nucleic Acid Delivery Excipients market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
Avanti Polar Lipids
Alfa Chemistry
Evonik Health Care
Phosphorex
Creative Biolabs
Celares
VectorBuilder
Seqens
BroadPharm
Entos
Gattefossé
Segment by Type
Cationic Lipids
pH-sensitive Lipids
Phospholipids
PEG Lipids
Lipid Nanoparticles for mRNA/siRNA/DNA
Transfection Vectors for Gene Therapies
Immunotherapies (CAR-T-Cells)
Lipid Prodrugs
Liposome Vectorization for Oncology
Others
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Nucleic Acid Delivery Excipients plant distribution, commercial date of Nucleic Acid Delivery Excipients, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Nucleic Acid Delivery Excipients introduction, etc. Nucleic Acid Delivery Excipients Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Nucleic Acid Delivery Excipients
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Global Nucleic Acid Delivery Excipients market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Nucleic Acid Delivery Excipients industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Nucleic Acid Delivery Excipients key manufacturers include Avanti Polar Lipids, Alfa Chemistry, Evonik Health Care, Phosphorex, Creative Biolabs, Celares, VectorBuilder, Seqens and BroadPharm, etc. Avanti Polar Lipids, Alfa Chemistry, Evonik Health Care are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Nucleic Acid Delivery Excipients were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Nucleic Acid Delivery Excipients market and estimated to attract more attentions from industry insiders and investors.
Nucleic Acid Delivery Excipients can be divided into Cationic Lipids, pH-sensitive Lipids, Phospholipids and PEG Lipids, etc. Cationic Lipids is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Nucleic Acid Delivery Excipients is widely used in various fields, such as Lipid Nanoparticles for mRNA/siRNA/DNA, Transfection Vectors for Gene Therapies, Immunotherapies (CAR-T-Cells) and Lipid Prodrugs, etc. Lipid Nanoparticles for mRNA/siRNA/DNA provides greatest supports to the Nucleic Acid Delivery Excipients industry development. In 2022, global % sales of Nucleic Acid Delivery Excipients went into Lipid Nanoparticles for mRNA/siRNA/DNA filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Nucleic Acid Delivery Excipients market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Nucleic Acid Delivery Excipients market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Avanti Polar Lipids
Alfa Chemistry
Evonik Health Care
Phosphorex
Creative Biolabs
Celares
VectorBuilder
Seqens
BroadPharm
Entos
Gattefossé
Segment by Type
Cationic Lipids
pH-sensitive Lipids
Phospholipids
PEG Lipids
Segment by Application
Lipid Nanoparticles for mRNA/siRNA/DNA
Transfection Vectors for Gene Therapies
Immunotherapies (CAR-T-Cells)
Lipid Prodrugs
Liposome Vectorization for Oncology
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Nucleic Acid Delivery Excipients plant distribution, commercial date of Nucleic Acid Delivery Excipients, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Nucleic Acid Delivery Excipients introduction, etc. Nucleic Acid Delivery Excipients Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Nucleic Acid Delivery Excipients
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices